Large-scale testing (Phase 3)Study completedNCT01872598What this trial is testingMasitinib in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease AB Science 721
Testing effectiveness (Phase 2)Study completedNCT03828747What this trial is testingSemorinemab in Patients With Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Genentech, Inc. 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946511What this trial is testingExploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe DementiaWho this might be right forDementia Ruijin Hospital 50
Not applicableStudy completedNCT04949984What this trial is testingBright Light Therapy in Older Adults With Moderate to Very Severe DementiaWho this might be right forDementiaMoodBehavior Universidade da Coruña 39
Large-scale testing (Phase 3)Study completedNCT00645190What this trial is testingA Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Xian-Janssen Pharmaceutical Ltd. 215
Post-approval studies (Phase 4)Study completedNCT01122329What this trial is testingA Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's DiseaseWho this might be right forAlzheimer Disease University of California, Los Angeles 17
Post-approval studies (Phase 4)WithdrawnNCT00375557What this trial is testingSafety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsWho this might be right forAlzheimer's DiseaseDementiaBehavioral Symptoms University of Cincinnati
Early research (Phase 1)Ended earlyNCT02614131What this trial is testingLY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)Who this might be right forHealthyAlzheimer's DiseaseMild Cognitive Impairment Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT02580305What this trial is testingSUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a StudyWho this might be right forAlzheimer's Disease Suven Life Sciences Limited 564
Testing effectiveness (Phase 2)Study completedNCT01397578What this trial is testingEvaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Genentech, Inc. 91
Post-approval studies (Phase 4)Study completedNCT00035204What this trial is testingThe Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Early research (Phase 1)Study completedNCT01716637What this trial is testingShort Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Life Extension Foundation Inc. 12
Post-approval studies (Phase 4)Study completedNCT00505167What this trial is testingMemantine Versus Donepezil in Early Stages of Alzheimer's DiseaseWho this might be right forDementia, Alzheimer Type Hospital Miguel Servet 64
Post-approval studies (Phase 4)Study completedNCT01921972What this trial is testingThe Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Charite University, Berlin, Germany 232
Not applicableStudy completedNCT01094145What this trial is testingDeep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease University of Cologne 6
Early research (Phase 1)Study completedNCT01230853What this trial is testingA Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose StudyWho this might be right forAlzheimer's Disease Eisai Inc. 80
Large-scale testing (Phase 3)Ended earlyNCT01883648What this trial is testingStudy to Evaluate Coconut Oil for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease University of South Florida 21
Testing effectiveness (Phase 2)Study completedNCT00443417What this trial is testingA Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease SK Chemicals Co., Ltd. 188
Very early researchNot Yet RecruitingNCT06836180What this trial is testingAn Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Xuanwu Hospital, Beijing 40
Testing effectiveness (Phase 2)Study completedNCT00377715What this trial is testingDouble-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Medivation, Inc. 183